Zim Laboratories

  • Market Cap: Micro Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: INE518E01015
  • NSEID: ZIMLAB
  • BSEID: 541400
INR
147.95
-0.2 (-0.13%)
BSENSE

Nov 20

BSE+NSE Vol: 1.43 lacs

  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
{
  "main_header": {
    "sid": 1000979,
    "name": "Zim Laboratories",
    "stock_name": "Zim Laboratories",
    "full_name": "Zim Laboratories Ltd",
    "name_url": "stocks-analysis/zim-laboratories",
    "exchange": 0,
    "exchangecode": "",
    "country_id": 34,
    "currency": "INR",
    "cmp": "147.95",
    "chg": -0.2,
    "chgp": "-0.13%",
    "dir": -1,
    "prev_price": "148.15",
    "mcapval": "801.00 Cr",
    "mcap": "Micro Cap",
    "scripcode": 541400,
    "symbol": "ZIMLAB",
    "ind_name": "Pharmaceuticals & Biotechnology",
    "ind_code": 4,
    "indexname": "",
    "isin": "INE518E01015",
    "curr_date": "Nov 20",
    "curr_time": "",
    "bse_nse_vol": "1.43 lacs",
    "exc_status": "Active",
    "traded_date": "Nov 20, 2026",
    "traded_date_str": "2026 11 20",
    "score": "",
    "scoreText": "",
    "Live": 0,
    "market_time": 0,
    "is_blur": 1,
    "is_blur_class": "blur-register-score-header",
    "is_blur_url": "https://researchintel.adityabirlamoney.com/ABML-Landingstocks-analysis/zim-laboratories-1000979-0&utm_source=Spage_Header_Score",
    "mojoone": {
      "ismore": 0
    }
  },
  "news": {
    "results": [
      {
        "title": "Zim Laboratories Ltd is Rated Sell by MarketsMOJO",
        "link": "https://researchintel.adityabirlamoney.com/news/stock-recommendation/zim-laboratories-ltd-is-rated-sell-by-marketsmojo-4270109",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/11/ZimLaboratories_mojoScore_4270109.png",
        "date": "2026-11-21 10:10:19",
        "description": "Zim Laboratories Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 05 May 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 21 November 2026, providing investors with an up-to-date perspective on the company’s performance and outlook."
      },
      {
        "title": "Zim Laboratories Ltd Valuation Shifts Signal Renewed Price Attractiveness",
        "link": "https://researchintel.adityabirlamoney.com/news/stocks-in-action/zim-laboratories-ltd-valuation-shifts-signal-renewed-price-attractiveness-4264644",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/11/ZimLaboratories_valuationdot_4264644.png",
        "date": "2026-11-17 08:02:11",
        "description": "Zim Laboratories Ltd, a micro-cap player in the Pharmaceuticals & Biotechnology sector, has witnessed a notable shift in its valuation parameters, moving from a fair to an attractive rating. Despite a recent day decline of 1.73%, the stock’s price-to-earnings (P/E) and price-to-book value (P/BV) ratios suggest a recalibration of price attractiveness relative to its historical and peer benchmarks."
      },
      {
        "title": "Zim Laboratories Ltd is Rated Sell by MarketsMOJO",
        "link": "https://researchintel.adityabirlamoney.com/news/stock-recommendation/zim-laboratories-ltd-is-rated-sell-by-marketsmojo-4257266",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/11/ZimLaboratories_mojoScore_4257266.png",
        "date": "2026-11-10 10:10:43",
        "description": "Zim Laboratories Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 05 May 2026. However, the analysis and financial metrics discussed here reflect the company’s current position as of 10 November 2026, providing investors with the most recent and relevant data to assess the stock’s outlook."
      },
      {
        "title": "Zim Laboratories Ltd Reports Mixed Quarterly Results Amid Margin Pressures",
        "link": "https://researchintel.adityabirlamoney.com/news/stocks-in-action/zim-laboratories-ltd-reports-mixed-quarterly-results-amid-margin-pressures-4254153",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/11/ZimLaboratories_fintrenddot_4254153.png",
        "date": "2026-11-06 11:01:11",
        "description": "Zim Laboratories Ltd, a micro-cap player in the Pharmaceuticals & Biotechnology sector, reported its September 2026 quarter results reflecting a shift from a previously flat to a negative financial trend. Despite robust net sales growth and record operating cash flow, the company’s profitability and return metrics deteriorated sharply, prompting a downgrade in its Mojo Grade to Sell from Strong Sell as of 5 May 2026."
      },
      {
        "title": "Zim Laboratories Gains 7.78%: 4 Key Factors Driving the Weekly Momentum",
        "link": "https://researchintel.adityabirlamoney.com/news/stocks-in-action/zim-laboratories-gains-778-4-key-factors-driving-the-weekly-momentum-4245764",
        "imagepath": "",
        "date": "2026-10-31 14:01:39",
        "description": "    <div class=\"article-news-new\">\n        <div class=\"article-container\">\n\n<div class=\"article-content\">\n                <div class=\"highlight-box\">\n                    <h3>Key Events This Week</h3>\n                    <p><strong>26 Oct:</strong> Technical momentum shifts amid mixed indicators; valuation turns attractive</p>\n                    <p><strong>27 Oct:</strong> Strong price gains continue, supported by positive volume and moving averages</p>\n                    <p><strong>29 Oct:</strong> Bullish momentum shift with 6.3% daily gain amid mixed technical signals</p>\n                    <p><strong>30 Oct:</strong> Technical momentum moderates to mildly bullish despite a slight price decline</p>\n                </div>\n\n                <div class=\"stats-row\">\n                    <div class=\"stat-item\"><div class=\"stat-label\">Week Open</div><div class=\"stat-value\">Rs.126.60</div></div>\n               ..."
      },
      {
        "title": "Zim Laboratories Ltd Technical Momentum Shifts Amid Mixed Indicator Signals",
        "link": "https://researchintel.adityabirlamoney.com/news/stocks-in-action/zim-laboratories-ltd-technical-momentum-shifts-amid-mixed-indicator-signals-4243961",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/10/ZimLaboratories_technicaldot_4243961.png",
        "date": "2026-10-30 08:02:24",
        "description": "Zim Laboratories Ltd, a micro-cap player in the Pharmaceuticals & Biotechnology sector, has experienced a nuanced shift in its technical momentum, moving from a bullish to a mildly bullish stance. Despite a day decline of 3.63%, the stock’s year-to-date return of 90.08% significantly outpaces the Sensex’s negative 12.99%, signalling underlying strength amid mixed technical signals."
      },
      {
        "title": "Zim Laboratories Ltd Sees Bullish Momentum Shift Amid Mixed Technical Signals",
        "link": "https://researchintel.adityabirlamoney.com/news/stocks-in-action/zim-laboratories-ltd-sees-bullish-momentum-shift-amid-mixed-technical-signals-4242803",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/10/ZimLaboratories_technicaldot_4242803.png",
        "date": "2026-10-29 08:02:40",
        "description": "Zim Laboratories Ltd, a micro-cap player in the Pharmaceuticals & Biotechnology sector, has experienced a notable shift in price momentum, moving from a mildly bullish to a bullish technical trend. Despite mixed signals from key indicators such as MACD, RSI, and moving averages, the stock’s recent performance and technical repositioning suggest a cautiously optimistic outlook for investors."
      },
      {
        "title": "Zim Laboratories Ltd is Rated Sell by MarketsMOJO",
        "link": "https://researchintel.adityabirlamoney.com/news/stock-recommendation/zim-laboratories-ltd-is-rated-sell-by-marketsmojo-4241809",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/10/ZimLaboratories_mojoScore_4241809.png",
        "date": "2026-10-28 10:11:02",
        "description": "Zim Laboratories Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 5 May 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 28 October 2026, providing investors with an up-to-date view of the company’s fundamentals, returns, and technical outlook."
      },
      {
        "title": "Zim Laboratories Ltd Technical Momentum Shifts Amid Mixed Indicators",
        "link": "https://researchintel.adityabirlamoney.com/news/stocks-in-action/zim-laboratories-ltd-technical-momentum-shifts-amid-mixed-indicators-4238316",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/10/ZimLaboratories_technicaldot_4238316.png",
        "date": "2026-10-26 08:02:33",
        "description": "Zim Laboratories Ltd, a micro-cap player in the Pharmaceuticals & Biotechnology sector, has experienced a notable shift in its technical momentum, moving from a bullish to a mildly bullish stance. Despite a day decline of 3.87% to close at ₹126.60, the stock’s technical indicators present a complex picture, with some signals pointing to strength while others suggest caution. This article analyses the recent technical parameter changes, key momentum indicators, and the implications for investors amid a volatile market backdrop."
      }
    ],
    "total": 72,
    "sid": "1000979",
    "stock_news_url": "https://researchintel.adityabirlamoney.com/news/zim-laboratories-1000979"
  },
  "announcements": [
    {
      "caption": "Announcement under Regulation 30 (LODR)-Earnings Call Transcript",
      "datetime": "11-Nov-2026",
      "details": "Transcript of Q2 & H1FY27 Earnings Conference Call",
      "source": "BSE"
    },
    {
      "caption": "Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome",
      "datetime": "05-Nov-2026",
      "details": "Please find enclosed the disclosure pertaining to the audio recording of Q2 & H1 FY27 Earnings Conference Call.",
      "source": "BSE"
    },
    {
      "caption": "Announcement under Regulation 30 (LODR)-Newspaper Publication",
      "datetime": "05-Nov-2026",
      "details": "Please find enclosed the Newspaper Publication of financial results for the Quarter & Half yearly ended 30th September 2026.",
      "source": "BSE"
    }
  ],
  "corporate_actions": [
    {
      "img": "board-meeting.svg",
      "title": "BOARD MEETING",
      "msg": "<span>No</span> Upcoming Board Meetings",
      "data": []
    },
    {
      "img": "dividend.svg",
      "title": "DIVIDEND",
      "msg": "",
      "data": [
        {
          "txt": "Zim Laboratories Ltd has declared <strong>5%</strong> dividend, ex-date: 19 Sep 19",
          "dt": "2019-09-19",
          "middle_text": "Dividend Alert"
        }
      ]
    },
    {
      "img": "splits.svg",
      "title": "SPLITS",
      "msg": "No <strong>Splits</strong> history available",
      "data": []
    },
    {
      "img": "bonus.svg",
      "title": "BONUS",
      "msg": "",
      "data": [
        {
          "txt": "Zim Laboratories Ltd has announced <strong>2:1</strong> bonus issue, ex-date: 22 Dec 22",
          "dt": "2022-12-22",
          "middle_text": "Bonus Alert"
        }
      ]
    },
    {
      "img": "rights-issues.svg",
      "title": "RIGHTS",
      "msg": "No <strong>Rights</strong> history available",
      "data": []
    }
  ]
}
stock newsNews and Views
stock-recommendationAnnouncement

Announcement under Regulation 30 (LODR)-Earnings Call Transcript

11-Nov-2026 | Source : BSE

Transcript of Q2 & H1FY27 Earnings Conference Call

Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome

05-Nov-2026 | Source : BSE

Please find enclosed the disclosure pertaining to the audio recording of Q2 & H1 FY27 Earnings Conference Call.

Announcement under Regulation 30 (LODR)-Newspaper Publication

05-Nov-2026 | Source : BSE

Please find enclosed the Newspaper Publication of financial results for the Quarter & Half yearly ended 30th September 2026.

stock-recommendationCorporate Actions
Corporate Actions
info
stock-summary
BOARD MEETING

No Upcoming Board Meetings

stock-summary
DIVIDEND

Zim Laboratories Ltd has declared 5% dividend, ex-date: 19 Sep 19

stock-summary
SPLITS

No Splits history available

stock-summary
BONUS

Zim Laboratories Ltd has announced 2:1 bonus issue, ex-date: 22 Dec 22

stock-summary
RIGHTS

No Rights history available